Abiopharma

ADC - ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update

Organon & Co. - Organon Reports Results for the Third Quarter Ended September 30, 2025

CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFERENCE

Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments

Agenus Inc. - Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances

Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update

ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update

Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025

Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances

Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships